Hanmi to lead cephalosporin antibiotic markets.

Hanmi announced on Aug. 29 that the company had completed a plant exclusively for the production of the cephalosporin antibiotics at Pyeongtaek and obtained the KGMP certification from the KFDA on Aug. 24 in conformance to the global standards, which required for a separated plant to produce at not only the world but also Korea until 2010.

The new plant was completed to construct in Jan. thi...